| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| Cost of Revenue | $0 | -100.0% |
| Gross Profit | $0 | -100.0% |
| R&D Expense | $712K | +154.2% |
| SG&A Expense | $140K | -15.3% |
| Operating Income | -$1.4M | +47.8% |
| Interest Expense | $2K | — |
| Income Tax | $0 | — |
| Net Income | -$1.4M |
| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12K | +8430.3% |
| Current Assets | $261K | +1535.9% |
| Total Assets | $261K | +1535.9% |
| Current Liabilities | $2.5M | +129.7% |
| Total Liabilities | $2.5M | +129.7% |
| Stockholders' Equity | -$2.2M | -108.8% |
| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$89K | -251.3% |
| Investing Cash Flow | $0 | — |
| Financing Cash Flow | $100K | — |